BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 19716967)

  • 1. New drugs for exacerbations of chronic obstructive pulmonary disease.
    Hansel TT; Barnes PJ
    Lancet; 2009 Aug; 374(9691):744-55. PubMed ID: 19716967
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel insights into the aetiology and pathophysiology of increased airway inflammation during COPD exacerbations.
    Tsoumakidou M; Siafakas NM
    Respir Res; 2006 May; 7(1):80. PubMed ID: 16716229
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exacerbations of chronic obstructive pulmonary disease.
    Wedzicha JA; Donaldson GC
    Respir Care; 2003 Dec; 48(12):1204-13; discussion 1213-5. PubMed ID: 14651761
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting defective pulmonary innate immunity - A new therapeutic option?
    Belchamber KBR; Donnelly LE
    Pharmacol Ther; 2020 May; 209():107500. PubMed ID: 32061706
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exacerbations of chronic obstructive pulmonary disease.
    Anzueto A; Sethi S; Martinez FJ
    Proc Am Thorac Soc; 2007 Oct; 4(7):554-64. PubMed ID: 17878469
    [TBL] [Abstract][Full Text] [Related]  

  • 6. On treating and preventing acute exacerbations in COPD.
    Singh A
    Proc Am Thorac Soc; 2008 Feb; 5(2):283; author reply 283. PubMed ID: 18250223
    [No Abstract]   [Full Text] [Related]  

  • 7. New insights into the immunology of chronic obstructive pulmonary disease.
    Brusselle GG; Joos GF; Bracke KR
    Lancet; 2011 Sep; 378(9795):1015-26. PubMed ID: 21907865
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms of Virus-Induced Airway Immunity Dysfunction in the Pathogenesis of COPD Disease, Progression, and Exacerbation.
    Guo-Parke H; Linden D; Weldon S; Kidney JC; Taggart CC
    Front Immunol; 2020; 11():1205. PubMed ID: 32655557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms of Chronic Obstructive Pulmonary Disease Exacerbations.
    Wedzicha JA
    Ann Am Thorac Soc; 2015 Nov; 12 Suppl 2():S157-9. PubMed ID: 26595732
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reducing airways inflammation to prevent exacerbations in chronic obstructive pulmonary disease.
    Roche N; Huchon G
    Allergy; 2005 Nov; 60(11):1350-6. PubMed ID: 16197465
    [No Abstract]   [Full Text] [Related]  

  • 11. [Novel therapeutics for COPD].
    Hoshino Y; Muro S; Mishima M
    Nihon Rinsho; 2011 Oct; 69(10):1826-30. PubMed ID: 22073581
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacotherapeutic approaches to preventing acute exacerbations of chronic obstructive pulmonary disease.
    Han MK; Martinez FJ
    Proc Am Thorac Soc; 2011 Aug; 8(4):356-62. PubMed ID: 21816992
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Infections and airway inflammation in chronic obstructive pulmonary disease severe exacerbations.
    Papi A; Bellettato CM; Braccioni F; Romagnoli M; Casolari P; Caramori G; Fabbri LM; Johnston SL
    Am J Respir Crit Care Med; 2006 May; 173(10):1114-21. PubMed ID: 16484677
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical inquiries: When are antibiotics indicated for acute COPD exacerbations?
    Balser E; Neher JO; Safranek S; Taraday J
    J Fam Pract; 2006 Dec; 55(12):1079-80. PubMed ID: 17137546
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emerging drugs for chronic obstructive pulmonary disease.
    Matera MG; Calzetta L; Segreti A; Cazzola M
    Expert Opin Emerg Drugs; 2012 Mar; 17(1):61-82. PubMed ID: 22335427
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Susceptibility to viral infections in chronic obstructive pulmonary disease: role of epithelial cells.
    Sajjan US
    Curr Opin Pulm Med; 2013 Mar; 19(2):125-32. PubMed ID: 23361194
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Innate immune recognition in infectious and noninfectious diseases of the lung.
    Opitz B; van Laak V; Eitel J; Suttorp N
    Am J Respir Crit Care Med; 2010 Jun; 181(12):1294-309. PubMed ID: 20167850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Future directions in the pharmacologic therapy of chronic obstructive pulmonary disease.
    Buhl R; Farmer SG
    Proc Am Thorac Soc; 2005; 2(1):83-93. PubMed ID: 16113474
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The benefits of long-term systemic antimicrobial therapy in chronic obstructive pulmonary disease.
    Berim I; Sethi S
    Ther Adv Respir Dis; 2011 Jun; 5(3):207-16. PubMed ID: 21378062
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Management of COPD: a review].
    Steurer-Stey C
    Praxis (Bern 1994); 2004 Oct; 93(41):1673-8. PubMed ID: 15535600
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.